Literature DB >> 19626340

In vitro and in vivo antifilarial potential of marine sponge, Haliclona exigua (Kirkpatrick), against human lymphatic filarial parasite Brugia malayi: antifilarial activity of H. exigua.

Vijai Lakshmi1, Shishir Srivastava, Sunil Kumar Mishra, Sweta Misra, Meenakshi Verma, Shailja Misra-Bhattacharya.   

Abstract

The present study reports on the antifilarial activity of a marine sponge Haliclona exigua (phylum Porifera). The crude methanol extract and n-butanol-soluble fraction killed adult Brugia malayi at 31.25-microg/ml concentration (both in motility and 3-(4,5 dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide assay) while the chloroform fraction was lethal at a lower concentration of 15.6 microg/ml. The activity could be located in a single molecule araguspongin C which brought about mortality of worm at 15.6 microg/ml. In vivo evaluation of the crude extract (5 x 500 mg/kg, orally) and the chloroform fraction (5 x 250 mg/kg, orally) in B. malayi-infected rodent host, Mastomys coucha, did not show any significant microfilaricidal actions; however, microfilarial densities in both the treated groups were significantly much lower than those of untreated group in contrast to standard filaricide diethylcarbamazine which exerted 79% microfilaricidal action on day 8 of treatment. Both these extracts also demonstrated adulticidal (macrofilaricidal) activity which was more pronounced in the chloroform fraction (50.2%). In addition, there was moderate adverse effect on the reproductive potential of female worms (crude extract 46.5%; chloroform 58.6%). The findings suggest that the marine sponge H. exigua possesses adulticidal and embryostatic action against human lymphatic filarial parasite B. malayi in experimental rodent model and this activity could be attributed to the presence of araguspongin C.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19626340     DOI: 10.1007/s00436-009-1555-1

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  26 in total

Review 1.  Marine natural products.

Authors:  D J Faulkner
Journal:  Nat Prod Rep       Date:  2001-02       Impact factor: 13.423

Review 2.  Drugs from the deep: marine natural products as drug candidates.

Authors:  Burkhard Haefner
Journal:  Drug Discov Today       Date:  2003-06-15       Impact factor: 7.851

3.  Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases.

Authors:  Karumanchi V Rao; Marwa S Donia; Jiangnan Peng; Esther Garcia-Palomero; Diana Alonso; Ana Martinez; Miguel Medina; Scott G Franzblau; Babu L Tekwani; Shabana I Khan; Subagus Wahyuono; Kristine L Willett; Mark T Hamann
Journal:  J Nat Prod       Date:  2006-07       Impact factor: 4.050

4.  Filaricidal efficacy of anthelmintically active cyclodepsipeptides.

Authors:  H Zahner; A Taubert; A Harder; G von Samson-Himmelstjerna
Journal:  Int J Parasitol       Date:  2001-11       Impact factor: 3.981

5.  The response to Litomosoides carinii to antifilarial agents in cotton rat (Sigmodon hispidus) & multimammate rat (Mastomys natalensis).

Authors:  S Misra; R K Chatterjee; A B Sen
Journal:  Indian J Med Res       Date:  1984-06       Impact factor: 2.375

6.  Effects of Bay 44-4400, a new cyclodepsipeptide, on developing stages of filariae (Acanthocheilonema viteae, Brugia malayi, Litomosoides sigmodontis) in the rodent Mastomys coucha.

Authors:  H Zahner; A Taubert; A Harder; G von Samson-Himmelstjerna
Journal:  Acta Trop       Date:  2001-09-01       Impact factor: 3.112

7.  Antifilarial activity of Zoanthus species (Phylum Coelenterata, Class Anthzoa) against human lymphatic filaria, Brugia malayi.

Authors:  V Lakshmi; A Saxena; K Pandey; Preeti Bajpai; Shailja Misra-Bhattacharya
Journal:  Parasitol Res       Date:  2004-05-15       Impact factor: 2.289

8.  The antifilarial activity of a marine red alga, Botryocladia leptopoda, against experimental infections with animal and human filariae.

Authors:  V Lakshmi; R Kumar; P Gupta; V Varshney; M N Srivastava; M Dikshit; P K Murthy; S Misra-Bhattacharya
Journal:  Parasitol Res       Date:  2004-07-09       Impact factor: 2.289

9.  4-Methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one: a novel DNA topoisomerase II inhibitor with adulticidal and embryostatic activity against sub-periodic Brugia malayi.

Authors:  Shailja Misra-Bhattacharya; Diksha Katiyar; Preeti Bajpai; R P Tripathi; J K Saxena
Journal:  Parasitol Res       Date:  2003-12-03       Impact factor: 2.289

10.  Immunomodulator tuftsin augments antifilarial activity of diethylcarbamazine against experimental brugian filariasis.

Authors:  M Owais; S Misra-Bhattacharya; W Haq; C M Gupta
Journal:  J Drug Target       Date:  2003-05       Impact factor: 5.121

View more
  10 in total

1.  Gedunin and photogedunin of Xylocarpus granatum possess antifilarial activity against human lymphatic filarial parasite Brugia malayi in experimental rodent host.

Authors:  Sweta Misra; Meenakshi Verma; Sunil Kumar Mishra; Shishir Srivastava; Vijai Lakshmi; Shailja Misra-Bhattacharya
Journal:  Parasitol Res       Date:  2011-04-27       Impact factor: 2.289

2.  Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model.

Authors:  Mohammad Ali; Mohammad Afzal; Meenakshi Verma; Shailja Misra Bhattacharya; F J Ahmad; Mohammad Samim; M Z Abidin; A K Dinda
Journal:  Parasitol Res       Date:  2013-12-24       Impact factor: 2.289

3.  Activity of Haliscosamine against Fusarium oxysporum f.sp. melonis: in vitro and in vivo analysis.

Authors:  Belakssem El Amraoui; Jean François Biard; Fatima Ez-Zohra Ikbal; Majida El Wahidi; Mostafa Kandil; Mohammed El Amraoui; Aziz Fassouane
Journal:  Springerplus       Date:  2015-01-13

Review 4.  Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2013-07-16       Impact factor: 5.118

5.  In vitro screening of antifungal activity of marine sponge extracts against five phytopathogenic fungi.

Authors:  Belkassem El Amraoui; Majida El Wahidi; Aziz Fassouane
Journal:  Springerplus       Date:  2014-10-24

Review 6.  The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases.

Authors:  Peter Mubanga Cheuka; Godfrey Mayoka; Peggoty Mutai; Kelly Chibale
Journal:  Molecules       Date:  2016-12-31       Impact factor: 4.411

Review 7.  Bioactive Nitrogenous Secondary Metabolites from the Marine Sponge Genus Haliclona.

Authors:  Jiaying Zhu; Yang Liu; Zijun Liu; Hao Wang; Huawei Zhang
Journal:  Mar Drugs       Date:  2019-12-03       Impact factor: 5.118

Review 8.  Marine-Derived Macrocyclic Alkaloids (MDMAs): Chemical and Biological Diversity.

Authors:  Hanan I Althagbi; Walied M Alarif; Khalid O Al-Footy; Ahmed Abdel-Lateff
Journal:  Mar Drugs       Date:  2020-07-17       Impact factor: 5.118

Review 9.  Recent advances on the use of biochemical extracts as filaricidal agents.

Authors:  Nazeh M Al-Abd; Zurainee Mohamed Nor; Abdulelah H Al-Adhroey; Anwar Suhaimi; S Sivanandam
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-05       Impact factor: 2.629

10.  Identification of Fromiamycalin and Halaminol A from Australian Marine Sponge Extracts with Anthelmintic Activity against Haemonchus contortus.

Authors:  H M P Dilrukshi Herath; Sarah Preston; Abdul Jabbar; Jose Garcia-Bustos; Aya C Taki; Russell S Addison; Sasha Hayes; Karren D Beattie; Sean L McGee; Sheree D Martin; Merrick G Ekins; John N A Hooper; Bill C H Chang; Andreas Hofmann; Rohan A Davis; Robin B Gasser
Journal:  Mar Drugs       Date:  2019-10-23       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.